IT major Tech Mahindra on Thursday announced that it will acquire 17.5 per cent stake in Altiostar Networks, a US-based telecom software development company for US$15 million.

In a bid to improve indirect tax revenue, Union government revised GST rates on 82 items. The government also gave several clarifications on rates implied on various services.

Overall volumes in futures & options currently stand at 1.70 crore contracts with a turnover of Rs. 16,58,044.44 crore.

Overall volumes in futures & options currently stand at 1.70 crore contracts with a turnover of Rs. 16,58,044.44 crore.

Going forward, immediate resistance is seen around 10,880-10,890, followed by 10,930, whereas support is seen around 10,770-10,780 and the next support is around 10,670. Top stocks in focus today: Dilip Buildcon, Tech Mahindra, Swan Energy, Karnataka Bank, Godrej Agrovet, Torrent Pharmaceuticals, Alembic, Biocon. 

Indian equity markets are likely to make a flat to positive start on Friday with traders eyeing third-quarter corporate earnings results of index heavyweights like HDFC Bank, Reliance, ITC, Wipro, Kotak Mahindra Bank for directional cues. The SGX Nifty indicates that the Nifty could open at 10,823 up by 12 points at the opening bell. 

The stocks that are likely to record significant movement on the bourses on January 19, 2018 are SPML Infra Limited, HDFC Bank/ITC Limited, Geojit Financial Services Limited and Biocon Limited. 

Infrastructure company SPML Infra along with its joint venture partner OM Metals Infraprojects bagged an international order worth Rs. 205 crore from the Ministry of Food and Agriculture, Republic of Ghana.

Engineering research and development company L&T Technology Services bagged an order worth Rs. 319 crore from a global aerospace electronic systems manufacturer, announced the company on Thursday.

Panacea Biotech has signed two agreements with Serum Institute of India (SII) and Bilthovan Biologicals (BBIO). Under this collaboration, SII is entitled to manufacture and sell fully liquid whole cell Pertussis (wP) and salk-based injectable polio vaccine (IPV), developed by Panacea Biotech.